Argatroban solution
Argatroban solution is mainly composed of Argatroban monohydrate (HY-B0375A). Argatroban monohydrate is a direct, selective thrombin inhibitor with anticoagulant properties, and can be used to alleviate motor paralysis caused by ischemic cerebral infarction.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 141396-28-3
- Formule: C23H38N6O6S
- Masse moléculaire:526.65
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Chemical Information
-
CAS No. 141396-28-3
-
Masse moléculaire 526.65
-
Formule C23H38N6O6S
-
SMILES
O=C(O)[C@@H]1N(CC[C@H](C1)C)C([C@H](CCCNC(N)=N)NS(=O)(C2=CC=CC3=C2NCC(C3)C)=O)=O.O
-
Synonyms
MD-805 monohydrate solution; MCI-9038 monohydrate solution
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Kawada, T., et al., Argatroban, an attractive anticoagulant, for left heart bypass with centrifugal pump for repair of traumatic aortic rupture. Jpn J Thorac Cardiovasc Surg, 1999. 47(3): p. 104-9. [Content Brief]
[2]. Jang, I.K., et al., A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study. J Am Coll Cardiol, 1999. 33(7): p. 1879-85. [Content Brief]
[3]. Hashimoto M, et al. Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model. Thromb Haemost. 2003 May;89(5):820-5. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)